Literature DB >> 1695836

Contact ulcers of the larynx. A reacquaintance with the pathology of an often underdiagnosed entity.

B M Wenig1, D K Heffner.   

Abstract

We reviewed the histologic features of 105 cases of contact ulcers of the larynx. Despite its characteristic clinical findings and correlative histopathology, the appropriate diagnosis was suggested in only one case. Instead, a descriptive diagnosis was most often rendered. Lesions for which this entity has been mistaken include pyogenic granuloma, hemangioma, hemangiopericytoma, Kaposi's sarcoma, angiosarcoma, spindle cell carcinoma, and granulomatous infectious diseases. Inappropriate diagnosis or failure to recognize the pathologic features of these lesions as correlating to a specific disease state deprives the patient of curative, well-established therapeutic procedures. We describe the histologic spectrum of contact ulcer of the larynx as well as its clinical findings, thereby familiarizing pathologists to an entity well recognized by otolaryngologists.

Entities:  

Mesh:

Year:  1990        PMID: 1695836

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

Review 1.  Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature.

Authors:  Brenda L Nelson; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2007-10-25

2.  Spindle cell lesions--neoplastic or non-neoplastic?: spindle cell carcinoma and other atypical spindle cell lesions of the head and neck.

Authors:  James S Lewis
Journal:  Head Neck Pathol       Date:  2008-05-28

Review 3.  Diagnostically challenging lesions in head and neck pathology.

Authors:  L D Thompson
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Potassium titanyl phosphate laser treatment of intubation vocal granuloma.

Authors:  Deng-Shan Lin; Shu-Chu Cheng; Wan-Fu Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-04       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.